Joe Leach, MD, discusses how comprehensive biomarker testing has impacted treatment selection for patients with small cell lung cancer. Joe Leach, MD, medical oncologist, associate medical director ...

The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...

SAN ANTONIO, December 12, 2024--bioAffinity reports successful execution of its pilot marketing program and steady growth in ...

Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The non-small cell lung cancer (NSCLC) drug osimertinib (Tagrisso) was associated ...

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) announces that the Norwegian healthcare region Helse Nord RHF will expand its usage of Sectra's enterprise imaging ...

A new laboratory study provides evidence about how advanced age can be protective against cancer — with implications for ...

A study from the University of Michigan Health Rogel Cancer Center may have—at last—cracked the cold case of immunotherapy ...

A study from the University of Michigan Health Rogel Cancer Center may have, at last, cracked the cold case of immunotherapy resistance.The research ...

A study from the University of Michigan Health Rogel Cancer Center may have ... Ph.D., director of the Michigan Center for Translational Pathology Kidney cancers, some melanomas, and non-small cell ...

4Department of Pathology, UT Southwestern Medical Center, Dallas, Texas. 5Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, Texas. 6Simmons Comprehensive Cancer ...

1Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. 2Oncode Institute, Utrecht, the Netherlands.

During Ms Lee’s hospital stay in 2016, doctors arranged for a biopsy, followed by genetic testing on a cancer-stricken lymph node to check for mutations causing non-small cell lung cancer (NSCLC).